BioVaxys Technology (BioVaxys Technology) Enterprise Value : $7.91 Mil (As of Jun. 08, 2024)

BioVaxys Technology Enterprise Value Chart

BioVaxys Technology Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Enterprise Value	Get a 7-Day Free Trial															10.67	16.47	8.76	4.42	2.26

Competitive Comparison of BioVaxys Technology's Enterprise Value

For the Biotechnology subindustry, BioVaxys Technology's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioVaxys Technology's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Enterprise Value falls into.

BioVaxys Technology Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BioVaxys Technology's Enterprise Value for the fiscal year that ended in Oct. 2022 is calculated as

BioVaxys Technology's Enterprise Value for the quarter that ended in Jul. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVaxys Technology  (OTCPK:BVAXF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BioVaxys Technology's EV-to-EBIT for today is

BioVaxys Technology's current Enterprise Value is $7.91 Mil.
BioVaxys Technology's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.36 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BioVaxys Technology's EV-to-EBITDA for today is:

BioVaxys Technology's current Enterprise Value is $7.91 Mil.
BioVaxys Technology's EBITDA for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.36 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BioVaxys Technology's EV-to-Revenue for today is:

BioVaxys Technology's current Enterprise Value is $7.91 Mil.
BioVaxys Technology's Revenue for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVaxys Technology Enterprise Value Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description